In the past ten years, the treatment
One article to understand, the diagnosis and treatment of Clostridium difficile infection
Time of Update: 2021-04-14
Edited by Yimaitong, please do not reprint
More than 7,700 hospitals in my country have established an appointment diagnosis and treatment system
Time of Update: 2021-03-26
Medical Network News on March 24, National Health Commission’s Planning Development
"Expert Consensus on Multidisciplinary Diagnosis and Treatment of Common Abdominal Infections in Surgery" released!
Time of Update: 2021-03-26
Local complications of severe acute pancreatitis (SAP) [Consensus 11] Infectious pancreatic necrosis (IPN) should be considered when SAP patients develop symptoms of infection such as fever and abdominal pain (level of evidence: low; strength of recommendation: strong recommendation).
Nat Immunol | Complement C5 inhibitor eculizumab in the treatment of CHAPLE disease-effectively
Time of Update: 2021-03-25
Finally, the author studied the changes in the intestinal flora and metabolic function of patients after eculizumab treatment.
US FDA approves Kimyrsa: treatment of acute bacterial skin and skin tissue infections
Time of Update: 2021-03-25
of the PK clinical trial, Dr. Michael Waters, said: "Kimyrsa is proven to be comparable to Orbactiv and has good safety. I am very pleased that these results support Kimyrsa's approval of the shorter infusion time and lower infusion
CAR-T cell side effects of infection | CAR-T cell treatment of NHL side effects clinical management expert consensus
Time of Update: 2021-03-23
>In this issue, the editor summarizes the infection part as follows for the reference of readers.
-
-
-
Diagnosis and treatment of necrotizing skin and soft tissue infections, a list of 2020 SIS guidelines!
Time of Update: 2021-03-23
[1B] ➤For rapidly progressive infections or severe infections caused by toxin-producing organisms, if the pathogen is sensitive to protein synthesis inhibitors clindamycin or linezolid, combination therapy should be considered.
my country's hierarchical diagnosis and treatment system has achieved initial results
Time of Update: 2021-03-23
During the "Thirteenth Five-Year Plan" period, China's county-level medical service capabilities have been significantly improved.
The number of two-way referrals nationwide has increased from 10.
Rongchang Biologics Class 1 new drug Tetazep has been approved to be marketed for the treatment of systemic lupus erythematosus
Time of Update: 2021-03-22
Taltazep is the first Chinese-made new drug for the treatment of systemic lupus erythematosus approved for marketing in China in decades.
GlaxoSmithKline's central nervous system treatment drug Rapidone approved for new indications for bipolar disorder
Time of Update: 2021-03-21
healthcare company, today announced that Rapidone (generic name: Lamotrigine Dispersible Tablets) has been awarded the National Medicines of China supervision and
-
-
-
-
-
-
-
-
-
Systemic Treatment of Advanced Liver Cancer: Yesterday, Today and Tomorrow｜Reviewing the Past and Knowing the New
Time of Update: 2021-03-21
The study showed that sorafenib compared with placebo treatment of advanced HCC prolonged the median overall survival (OS) period by 2.
bacteria in the treatment of recurrent Clostridium difficile infection
Time of Update: 2021-03-17
The effect of a microbial ecosystem therapeutic (MET-2) on recurrent Clostridioides difficile infection: a phase 1, open-label, single-group trial .
Autophagy: New ideas for HIV infection treatment! Scientists have developed an innovative treatment to optimize the host immune system to eliminate HIV!
Time of Update: 2021-02-27
for Labor Safety and Research developed a new treatment to restore the effectiveness of immune cells. Many people infected with HIV-1 require routine antiviral therapy to control infection in the body, however these drugs often induce significant side
PCR in the genetic diagnosis of viral infection
Time of Update: 2021-02-27
total RNA extraction using reverse transcriptase synthesis c DNA PCR reaction: reactor tissue: reaction buffer template (synthetic cDNA
FDA approves new treatments for complex urinary tract and complex celiac infections
Time of Update: 2021-02-24
The U.S. Food and Drug Administration has approved Recarbrio (aamine pernam, sestatins, and relebactam), an antibacterial drug product used to treat adult patients with complex urinary tract infections (cUTI) and intracarosis infections (cIAI).
Virus-like Particle and Viral Vector Production Using the Baculovirus Expression Vector System
Time of Update: 2021-02-22
The ability to make a large variety of virus-like particles (VLPs) has been successfully achieved in the baculovirus expression vector system (BEVS)/insect cell system.
State Council joint prevention and control mechanism: hospitals may not delay infection prevention and control to push patients for treatment
Time of Update: 2021-02-12
The Joint Prevention and Control Mechanism of the State Council recently issued a notice that the current situation of prevention and control of the new crown pneumonia epidemic is serious and complex, there are medical institutions infection
In-depth interpretation: the role of probiotics in the treatment of pneumonia with new coronavirus infections
Time of Update: 2021-02-09
Probiotics, as one of the intestinal micro-ecological regulators, are included in the pneumonia diagnosis and treatment programme for new coronavirus infections the balance of intestinal micro-ecologicals is included as part
JAMA: Bamlanivimab-etesevimab combined treatment reduces viral load in patients with neo-coronary pneumonia
Time of Update: 2021-01-31
recently compared the treatment effects of Bamlanivimab single-drug or in association with medium-to-moderate anti-Etesevimab for patients with mild and moderate neo-coronary pneumonia. BLAZE-1 study was a Phase II-III clinical study conducted
